The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
array biopharma | 2597 |
genentech | 466 |
astrazeneca | 150 |
intermune | 112 |
ventirx pharmaceuticals | 109 |
novartis | 91 |
irm | 43 |
roche | 27 |
amgen | 15 |
loxo oncology | 13 |
array biopharma | 231 |
genentech | 49 |
intermune | 32 |
astrazeneca | 13 |
amgen | 3 |
brad newhouse | 3 |
ehrrej bajofarma ink. | 1 |
ehrrehj biofarma | 1 |
gentech | 1 |
ehrrehj biofarma ink. | 1 |
array biopharma | 201 |
genentech | 35 |
loxo oncology | 11 |
ventirx pharmaceuticals | 4 |
astrazeneca | 3 |
mirati therapeutics | 3 |
celgene corporation | 2 |
novartis | 1 |
roche | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
n3 alkylated benzimidazole derivatives as mek inhibitors | 98 | 2002 |
substituted pyrazolo[1,5-a]pyrimidine compounds as trk kinase inhibitors | 93 | 2008 |
heterocyclic inhibitors of mek and methods of use thereof | 87 | 2003 |
compounds and compositions as protein kinase inhibitors | 79 | 2009 |
p38 inhibitors and methods of use thereof | 79 | 2003 |
hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors | 77 | 2006 |
macrocyclic compounds as trk kinase inhibitors | 72 | 2010 |
heterocyclic inhibitors of mek and methods of use thereof | 70 | 2005 |
6-substituted phenoxychroman carboxylic acid derivatives | 59 | 2008 |
serine/threonine kinase inhibitors | 56 | 2012 |